cefuroxime has been researched along with Kidney Diseases in 16 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Renal parenchymal malacoplakia is a rare cause of acute renal failure." | 2.42 | Renal parenchymal malacoplakia: a rare cause of ARF with a review of recent literature. ( Chan, KW; Kung, WH; Li, R; Tam, VK, 2003) |
| " The concentration of drug in serum and urine was measured during treatment, and pharmacokinetic parameters were evaluated on the second and last days; the parameters obtained on the 2 days did not differ significantly." | 1.27 | Pharmacokinetics and clinical effects of cefuroxime in patients with severe renal insufficiency. ( Berg, KJ; Nilsen, OG; Walstad, RA, 1983) |
| " During IHF the mean terminal half-life of cefuroxime was 1." | 1.27 | Pharmacokinetics of intravenous cefuroxime during intermittent and continuous arteriovenous hemofiltration. ( Cars, O; Danielson, BG; Grahnen, A; Weiss, LG; Wikström, B, 1988) |
| "3 Cefuroxime was cleared, unchanged, almost exclusively by the kidneys, even when kidney function was impaired." | 1.26 | Pharmacokinetic study of cefuroxime in the elderly. ( Broekhuysen, J; Deger, F; Douchamps, J; Freschi, E; Mal, N; Neve, P; Parfait, R; Siska, G; Winand, M, 1981) |
| "However, an eighth patient with acute renal failure caused by bacteraemic shock rapidly recovered renal function while being treated with cefuroxime and gentamicin for 15 days after large doses of frusemide intravenously." | 1.26 | The safety of cefuroxime and gentamicin in patients with reduced renal function. ( Bax, RP; Cockram, CS; Richards, P, 1980) |
| " This dosage of cefuroxime was protective when given for only two consecutive days starting on the first to third days of gentamicin treatment, but enhanced gentamicin nephrotoxocity when started on the sixth or subsequent days." | 1.26 | Effect of timing of cefuroxime dosage on its protection of rats against gentamicin nephrotoxicity. ( Atkinson, RM; Capel-Edwards, K; Foord, RD; Harman, IW; Patterson, GG; Pratt, DA; Wheeldon, JM, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (62.50) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Taskinen, S | 1 |
| Giordano, S | 1 |
| Rintala, R | 1 |
| Reirden, DH | 1 |
| Menchise, AN | 1 |
| Knox, B | 1 |
| Gereige, R | 1 |
| Howard, T | 1 |
| Thomas, EL | 1 |
| Connelly, R | 1 |
| Tyler, S | 1 |
| McPeak, K | 1 |
| Ladhani, S | 1 |
| Gransden, W | 1 |
| Tam, VK | 1 |
| Kung, WH | 1 |
| Li, R | 1 |
| Chan, KW | 1 |
| Calvert, LD | 1 |
| Collins, M | 1 |
| Bateman, JR | 1 |
| Trollfors, B | 2 |
| Alestig, K | 1 |
| Rödjer, S | 1 |
| Sandberg, T | 1 |
| Westin, J | 1 |
| Suurkula, M | 1 |
| Price, JD | 1 |
| Norrby, R | 1 |
| Walstad, RA | 1 |
| Nilsen, OG | 1 |
| Berg, KJ | 1 |
| Weinstein, AJ | 1 |
| Bundtzen, RW | 1 |
| Toothaker, RD | 1 |
| Nielson, OS | 1 |
| Madsen, PO | 1 |
| Welling, PG | 1 |
| Craig, WA | 1 |
| Broekhuysen, J | 1 |
| Deger, F | 1 |
| Douchamps, J | 1 |
| Freschi, E | 1 |
| Mal, N | 1 |
| Neve, P | 1 |
| Parfait, R | 1 |
| Siska, G | 1 |
| Winand, M | 1 |
| Cockram, CS | 1 |
| Richards, P | 1 |
| Bax, RP | 1 |
| Capel-Edwards, K | 1 |
| Atkinson, RM | 1 |
| Wheeldon, JM | 1 |
| Pratt, DA | 1 |
| Patterson, GG | 1 |
| Harman, IW | 1 |
| Foord, RD | 1 |
| Odeh, M | 1 |
| Oliven, A | 1 |
| Cantu, TG | 1 |
| Fantozzi, D | 1 |
| Weiss, LG | 1 |
| Cars, O | 1 |
| Danielson, BG | 1 |
| Grahnen, A | 1 |
| Wikström, B | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Treatment of Febrile Infectious Disease Among Children in Hadera District Given the Final Diagnosis. Descriptive Study[NCT02313532] | 500 participants (Anticipated) | Observational | 2015-01-31 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for cefuroxime and Kidney Diseases
| Article | Year |
|---|---|
Renal parenchymal malacoplakia: a rare cause of ARF with a review of recent literature.
Topics: Acute Kidney Injury; Aged; Biopsy, Needle; Cefuroxime; Diagnosis, Differential; Drug Therapy, Combin | 2003 |
The cephalosporins: activity and clinical use.
Topics: Cefaclor; Cefamandole; Cefatrizine; Cefazolin; Cefoxitin; Cefuroxime; Cephacetrile; Cephalexin; Ceph | 1980 |
1 trial available for cefuroxime and Kidney Diseases
| Article | Year |
|---|---|
Renal function in patients treated with tobramycin-cefuroxime or tobramycin-penicillin G.
Topics: beta 2-Microglobulin; Cefuroxime; Cephalosporins; Chromium Radioisotopes; Drug Interactions; Drug Th | 1983 |
13 other studies available for cefuroxime and Kidney Diseases
| Article | Year |
|---|---|
Xanthogranulomatous pyelonephritis infiltrating the liver.
Topics: Anti-Bacterial Agents; Cefuroxime; Cephalexin; Child; Clindamycin; Combined Modality Therapy; Divert | 2008 |
Index of suspicion.
Topics: Abscess; Adolescent; Anti-Bacterial Agents; Brucellosis; Cefuroxime; Child; Doxycycline; Female; Gen | 2009 |
Increasing antibiotic resistance among urinary tract isolates.
Topics: Adolescent; Anti-Bacterial Agents; Cefuroxime; Child; Ciprofloxacin; Drug Resistance, Bacterial; Esc | 2003 |
Multiple abscesses caused by Gardnerella vaginalis in an immunocompetent man.
Topics: Abdominal Abscess; Bacterial Infections; Cefuroxime; Empyema, Pleural; Gardnerella vaginalis; Humans | 2005 |
Renal function during cefuroxime treatment in patients with pre-existing renal impairment.
Topics: Cefuroxime; Cephaloridine; Cephalosporins; Edetic Acid; Furosemide; Gentamicins; Glomerular Filtrati | 1980 |
Pharmacokinetics and clinical effects of cefuroxime in patients with severe renal insufficiency.
Topics: Aged; Cefuroxime; Cephalosporins; Creatinine; Female; Furosemide; Humans; Kidney Diseases; Kinetics; | 1983 |
Pharmacokinetics of cefuroxime in normal and impaired renal function: comparison of high-pressure liquid chromatography and microbiological assays.
Topics: Adult; Biological Assay; Cefuroxime; Cephalosporins; Chromatography, High Pressure Liquid; Creatine; | 1981 |
Pharmacokinetic study of cefuroxime in the elderly.
Topics: Aged; Cefuroxime; Cephalosporins; Female; Humans; Kidney Diseases; Kinetics; Lung Diseases; Male; Sp | 1981 |
The safety of cefuroxime and gentamicin in patients with reduced renal function.
Topics: Acute Kidney Injury; Adult; Aged; Bacteriuria; Cefuroxime; Cephalosporins; Drug Therapy, Combination | 1980 |
Effect of timing of cefuroxime dosage on its protection of rats against gentamicin nephrotoxicity.
Topics: Animals; Cefuroxime; Cephalosporins; Gentamicins; Kidney; Kidney Diseases; Male; Rats; Time Factors | 1980 |
Acute brucellosis associated with massive proteinuria.
Topics: Acute Disease; Brucellosis; Cefuroxime; Cephalosporins; Diabetes Mellitus, Type 2; Female; Humans; K | 1996 |
Cefuroxime dosage in renal failure.
Topics: Cefuroxime; Cephalosporins; Humans; Kidney Diseases; Reference Books | 1988 |
Pharmacokinetics of intravenous cefuroxime during intermittent and continuous arteriovenous hemofiltration.
Topics: Aged; Cefuroxime; Cephalosporins; Hemofiltration; Humans; Infusions, Intravenous; Kidney Diseases; M | 1988 |